Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary EDAP Reports Conference Success
Clinical Updates Presented From French Luminary Centers, Marketing Programs Attracting Inquiries
View HTML
Toggle Summary EDAP Appoints Soyer CFO
Adds to Executive Team for Ongoing Growth, Expansion
View HTML
Toggle Summary EDAP TMS S.A. Reports 2006 Third Quarter Results
EDAP and HealthTronics in Discussions Realigning US Market Entry; Ablatherm RPP Success Growing Europe; Lithotripsy Returns to Profitability - Solid Cash Position for Continued Growth
View HTML
Toggle Summary EDAP TMS S.A. to Participate in International Urology Conferences
EDAP TMS S.A. to Participate in International Urology Conferences LYON, France -- EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, today announces it is actively participating in the Societe Internationale d'Urologie (SIU)
View HTML
Toggle Summary Ablatherm-HIFU featured in UroToday.com Electronic Newsletter
Ablatherm-HIFU featured in UroToday.com Electronic Newsletter EDAP and Ablatherm-HIFU were recently featured in an email distributed by UroToday.com to more than 10,000 urologists advising them of the site's HIFU Resource Center. Urotoday.com, located at http://www.urotoday.com , is one of the top
View HTML
Toggle Summary EDAP TMS S.A. Adds to Clinical Depth
Recent Studies Confirm Repeatability of Outcomes, Lower Side Effects for Ablatherm-HIFU
View HTML
Toggle Summary EDAP Launches RPP Service at Major German Hospital; Updates Progress of German Marketing
Marketing Efforts Advancing Ablatherm-HIFU in Key Global Market
View HTML
Toggle Summary News Article: Ultrasound Waves Being Used To Treat Prostate Cancer
The following article appeared September 27, 2006 in WRAL.com serving the Raleigh-Durham & Fayetteville, North Carolina areas. The story can be viewed at http://www.wral.com/health/9947426/detail.html. Ultrasound Waves Being Used To Treat Prostate Cancer
View HTML
Toggle Summary Webcast: EDAP Presentation at Roth Capital Conference
Webcast: EDAP Presentation at Roth Capital Conference EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, presented at the Roth Capital Partners New York Conference on September 6, 2006 at the Westin Time Square Hotel in New
View HTML
Toggle Summary EDAP TMS S.A. to Present at Roth Capital Conference in New York
EDAP TMS S.A. to Present at Roth Capital Conference in New York Lyon, France, August 24, 2006 - EDAP TMS S.A. (Nasdaq: EDAP) , the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, announced management will present at the Roth Capital Partners New York
View HTML